Kyverna Therapeutics (KYTX) Shares Issued (2023 - 2026)
Kyverna Therapeutics (KYTX) posted Shares Issued of $10.7 million for Q1 2026, up 14.24% on a QoQ basis from $9.3 million in Q4 2025, and up 487.9% year-over-year from $1.8 million in Q1 2025.
Kyverna Therapeutics (KYTX) Shares Issued (2023 - 2026) Analysis & Trends
Kyverna Therapeutics' Shares Issued history runs 4 years deep, the most recent figure standing at $10.7 million for Q1 2026.
- Quarterly Shares Issued rose 487.9% year-over-year to $10.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.7 million (up 487.9% YoY) and the FY2025 annual result came in at $9.3 million, up 22.84% from the prior year.
- Shares Issued was $10.7 million for Q1 2026 at Kyverna Therapeutics, up from $9.3 million in the prior quarter.
- Across five years, Shares Issued topped out at $10.7 million in Q1 2026 and bottomed at $1.8 million in Q1 2025.
- A 4-year average of $6.9 million and a median of $7.4 million in 2024 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2025 — Shares Issued plunged 57.12% — and 2026, when it soared 487.9%.
- Kyverna Therapeutics' Shares Issued stood at $4.3 million in 2023, then jumped by 76.24% to $7.6 million in 2024, then rose by 22.84% to $9.3 million in 2025, then climbed by 14.24% to $10.7 million in 2026.
- Business Quant data shows KYTX's Shares Issued at $10.7 million in Q1 2026, $9.3 million in Q4 2025, and $9.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 19.44 Mn |
| 10 | Kyverna Therapeutics | 440.57 Mn | 440.57 Mn | - | 10.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.66 Mn |
| Mar 31, 2026 | 10.66 Mn |
| Dec 31, 2025 | 9.33 Mn |
| Dec 31, 2025 | 9.33 Mn |
| Sep 30, 2025 | 9.44 Mn |
| Sep 30, 2025 | 9.44 Mn |
| Jun 30, 2025 | 9.94 Mn |
| Jun 30, 2025 | 9.94 Mn |
| Mar 31, 2025 | 1.81 Mn |
| Mar 31, 2025 | 1.81 Mn |
| Dec 31, 2024 | 7.60 Mn |
| Dec 31, 2024 | 7.60 Mn |
| Sep 30, 2024 | 7.11 Mn |
| Sep 30, 2024 | 7.11 Mn |
| Jun 30, 2024 | 4.17 Mn |
| Jun 30, 2024 | 4.17 Mn |
| Mar 31, 2024 | 4.23 Mn |
| Mar 31, 2024 | 4.23 Mn |
| Dec 31, 2023 | 4.31 Mn |
| Dec 31, 2023 | 4.31 Mn |